<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346336</id>
  <title nil="true"/>
  <common-name>3-[3-oxo-3-(4-phenylpiperazin-1-yl)propyl]-2-phenylquinazolin-4-one</common-name>
  <description>3-[3-oxo-3-(4-phenylpiperazin-1-yl)propyl]-2-phenylquinazolin-4-one is a chemical compound with the formula C27H26N4O2. It has an average molecular weight of 438.50 g/mol.</description>
  <cas>70540-67-9</cas>
  <pubchem-id>3053881</pubchem-id>
  <chemical-formula>C27H26N4O2</chemical-formula>
  <weight>438.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:44:55Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:44:55Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1CN(CCN1C2=CC=CC=C2)C(=O)CCN3C(=NC4=CC=CC=C4C3=O)C5=CC=CC=C5</moldb-smiles>
  <moldb-formula>C27H26N4O2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H26N4O2/c32-25(30-19-17-29(18-20-30)22-11-5-2-6-12-22)15-16-31-26(21-9-3-1-4-10-21)28-24-14-8-7-13-23(24)27(31)33/h1-14H,15-20H2</moldb-inchi>
  <moldb-inchikey>ISYCMUFFWOQJFS-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">438.2055761</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342229</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[3-oxo-3-(4-phenylpiperazin-1-yl)propyl]-2-phenylquinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296689</sync-id>
  <structure-inchikey>ISYCMUFFWOQJFS-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000100001000000000000000000000000000000000000000040000020000000000000002004000100000000000000000000200080000000000000000000000000000000000020000000010000000000008000008000000000210040000000000000000000000000020100000000000000280040000000004000000000804000000000004000800000000100000000000000000000000000000000000000040000080000060000000000000000008000000800000000000008040004000000000000000000000000008000002000000200000000000000020040000001000040000000000400000000000000000000004000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJQAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:06Z</structure-indexed-at>
</compound>
